These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20628206)

  • 1. [Animal models of Alzheimer's disease for preclinical research.].
    Takahashi H
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):6-10. PubMed ID: 20628206
    [No Abstract]   [Full Text] [Related]  

  • 2. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for better animal models of Alzheimer's disease.
    King A
    Nature; 2018 Jul; 559(7715):S13-S15. PubMed ID: 30046083
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel approaches to models of Alzheimer's disease pathology for drug screening and development.
    Shaughnessy L; Chamblin B; McMahon L; Nair A; Thomas MB; Wakefield J; Koentgen F; Ramabhadran R
    J Mol Neurosci; 2004; 24(1):23-32. PubMed ID: 15314246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Alzheimer's disease therapeutics.
    Rafii MS
    J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine.
    Goodarzi P; Payab M; Alavi-Moghadam S; Larijani B; Rahim F; Bana N; Sarvari M; Adibi H; Foroughi Heravani N; Hadavandkhani M; Arjmand B
    Cell Tissue Bank; 2019 Jun; 20(2):141-151. PubMed ID: 31087217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMSO modulates CNS function in a preclinical Alzheimer's disease model.
    Penazzi L; Lorengel J; Sündermann F; Golovyashkina N; Marre S; Mathis CMB; Lewejohann L; Brandt R; Bakota L
    Neuropharmacology; 2017 Feb; 113(Pt A):434-444. PubMed ID: 27773645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule targeting the multifactorial nature of Alzheimer's disease.
    Cavalli A; Bolognesi ML; Capsoni S; Andrisano V; Bartolini M; Margotti E; Cattaneo A; Recanatini M; Melchiorre C
    Angew Chem Int Ed Engl; 2007; 46(20):3689-92. PubMed ID: 17397121
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell cultures from animal models of Alzheimer's disease as a tool for faster screening and testing of drug efficacy.
    Trinchese F; Liu S; Ninan I; Puzzo D; Jacob JP; Arancio O
    J Mol Neurosci; 2004; 24(1):15-21. PubMed ID: 15314245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease.
    Smith JD; Chakrabarti E; Levin-Allerhand JA
    J Mol Neurosci; 2004; 24(1):145-7. PubMed ID: 15314263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer's disease. Molecular pathology, animal models, and current treatment].
    Bayer TA; Wirths O
    Nervenarzt; 2008 Nov; 79 Suppl 3():117-25; quiz 126-7. PubMed ID: 18820894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of Alzheimer's disease and drug development.
    Laurijssens B; Aujard F; Rahman A
    Drug Discov Today Technol; 2013 Sep; 10(3):e319-27. PubMed ID: 24050129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid drug screening for Alzheimer's.
    Döbeli H
    Nat Biotechnol; 1997 Mar; 15(3):223-4. PubMed ID: 9062918
    [No Abstract]   [Full Text] [Related]  

  • 16. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
    Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
    Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dihydrotestosterone on gastrointestinal tract of male Alzheimer's disease transgenic mice.
    Karri S; Acosta-Martinez V; Coimbatore G
    Indian J Exp Biol; 2010 May; 48(5):453-65. PubMed ID: 20795362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV; Okun I; Aladinskiy V; Ivanenkov Y; Koryakova A; Karapetyan R; Mitkin O; Salimov R; Ivashchenko A
    J Alzheimers Dis; 2017; 58(4):1043-1063. PubMed ID: 28550249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria.
    Strobel G
    J Alzheimers Dis; 2009; 18(4):973-90. PubMed ID: 20009238
    [No Abstract]   [Full Text] [Related]  

  • 20. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.
    Zhou W; Zhong G; Fu S; Xie H; Chi T; Li L; Rao X; Zeng S; Xu D; Wang H; Sheng G; Ji X; Liu X; Ji X; Wu D; Zou L; Tortorella M; Zhang K; Hu W
    ACS Chem Neurosci; 2016 Nov; 7(11):1499-1507. PubMed ID: 27504670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.